About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire

Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire

NCT01547351·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Mallinckrodt

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Informed consent and HIPAA authorization must be obtained from the patient prior to any study-related procedures.
Patient is ≥ 18 years of age at the time of participation
Patient has confirmed MS relapse.
Patient must have been treated with oral or IV corticosteroids for their previous relapse.
Willingness to comply with all procedures and assessments.

You may not be if

Patient has pseudorelapse.
Patient was treated with any therapies other than corticosteroids for their previous relapse.
Any other condition which, in the opinion of the investigator, would not allow proper completion of this study.

The record

StatusCompleted

PhaseNo phase

Taking part103

StartedDec 2011

UpdatedOct 19, 2016

Conditions

Multiple Sclerosis

Where5

Tanner Center and Foundation for MS
Birmingham, Alabama, United States
Neurology Center
Oceanside, California, United States
Infinity Clinical Research
Hollywood, Florida, United States